Cell-based Assays Market Size, Share & Trends Analysis Report By Products & Services (Reagents, Assay Kits), By Application (Basic Research, Drug Discovery), By End-use, By Region, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Segment Definitions
                        1.2.1. Products & Services
                        1.2.2. Application
                        1.2.3. End Use
                        1.2.4. Regional Scope
                        1.2.5. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Regional outlook
                    2.4. Competitive Insights
Chapter 3. Cell-based Assays Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Rising Prevalence of Chronic Diseases
                            3.2.1.2. Growing Focus on Personalized Medicine
                            3.2.1.3. Technological Advancements
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Complexity of Assay Development
                            3.2.2.2. Lack of Standardization
                    3.3. Cell-based Assays Market Analysis Tools
                        3.3.1. Industry Analysis – Porter’s
                            3.3.1.1. Bargaining power of suppliers
                            3.3.1.2. Bargaining power of buyers
                            3.3.1.3. Threat of substitutes
                            3.3.1.4. Threat of new entrants
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Economic landscape
                            3.3.2.3. Social landscape
                            3.3.2.4. Technological landscape
                            3.3.2.5. Environmental landscape
                            3.3.2.6. Legal landscape
Chapter 4. Cell-based Assays Market: Products & Services Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Cell-based Assays Market: Products & Services Movement Analysis
                    4.3. Cell-based Assays Market by Products & Services Outlook (USD Million)
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    4.5. Reagents
                        4.5.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.6. Assay Kits
                        4.6.1. Assay Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.6.2. Cell Growth Assays
                            4.6.2.1. Cell Growth Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.6.3. Reporter Gene Assays
                            4.6.3.1. Reporter Gene Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.6.4. Cell Death Assays
                            4.6.4.1. Cell Death Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.6.5. Second Messenger Assays
                            4.6.5.1. Second Messenger Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.7. Microplates
                        4.7.1. Microplates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.8. Probes & Labels
                        4.8.1. Probes & Labels Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.9. Instruments & Software
                        4.9.1. Instruments & Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.10. Cell Lines
                        4.10.1. Cell Lines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.10.2. Primary Cell Lines
                            4.10.2.1. Primary Cell Lines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.10.3. Stem Cell Lines
                            4.10.3.1. Stem Cell Lines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.10.4. Immortalized Cell Lines
                            4.10.4.1. Immortalized Cell Lines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Cell-based Assays Market: Application Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Cell-based Assays Market: Application Movement Analysis
                    5.3. Cell-based Assays Market by Application Outlook (USD Million)
                    5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    5.5. Basic Research
                        5.5.1. Basic Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.6. Drug Discovery
                        5.6.1. Drug Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.7. Other Applications
                        5.7.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Cell-based Assays Market: End Use Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Cell-based Assays Market: End Use Movement Analysis
                    6.3. Cell-based Assays Market by End Use Outlook (USD Million)
                    6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    6.5. Pharmaceutical & Biotechnology Companies
                        6.5.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.6. Academic & Research Institutes
                        6.6.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.7. Contract Research Organizations
                        6.7.1. Contract Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Cell-based Assays Market: Regional Estimates & Trend Analysis
                    7.1. Regional Dashboard
                    7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                    7.3. North America
                        7.3.1. U.S.
                            7.3.1.1. Key country dynamics
                            7.3.1.2. Regulatory framework/ reimbursement structure
                            7.3.1.3. Competitive scenario
                            7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
                        7.3.2. Canada
                            7.3.2.1. Key country dynamics
                            7.3.2.2. Regulatory framework/ reimbursement structure
                            7.3.2.3. Competitive scenario
                            7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
                        7.3.3. Mexico
                            7.3.3.1. Key country dynamics
                            7.3.3.2. Regulatory framework/ reimbursement structure
                            7.3.3.3. Competitive scenario
                            7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
                    7.4. Europe
                        7.4.1. UK
                            7.4.1.1. Key country dynamics
                            7.4.1.2. Regulatory framework/ reimbursement structure
                            7.4.1.3. Competitive scenario
                            7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
                        7.4.2. Germany
                            7.4.2.1. Key country dynamics
                            7.4.2.2. Regulatory framework/ reimbursement structure
                            7.4.2.3. Competitive scenario
                            7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
                        7.4.3. France
                            7.4.3.1. Key country dynamics
                            7.4.3.2. Regulatory framework/ reimbursement structure
                            7.4.3.3. Competitive scenario
                            7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
                        7.4.4. Italy
                            7.4.4.1. Key country dynamics
                            7.4.4.2. Regulatory framework/ reimbursement structure
                            7.4.4.3. Competitive scenario
                            7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
                        7.4.5. Spain
                            7.4.5.1. Key country dynamics
                            7.4.5.2. Regulatory framework/ reimbursement structure
                            7.4.5.3. Competitive scenario
                            7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
                        7.4.6. Norway
                            7.4.6.1. Key country dynamics
                            7.4.6.2. Regulatory framework/ reimbursement structure
                            7.4.6.3. Competitive scenario
                            7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
                        7.4.7. Sweden
                            7.4.7.1. Key country dynamics
                            7.4.7.2. Regulatory framework/ reimbursement structure
                            7.4.7.3. Competitive scenario
                            7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
                        7.4.8. Denmark
                            7.4.8.1. Key country dynamics
                            7.4.8.2. Regulatory framework/ reimbursement structure
                            7.4.8.3. Competitive scenario
                            7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
                    7.5. Asia Pacific
                        7.5.1. Japan
                            7.5.1.1. Key country dynamics
                            7.5.1.2. Regulatory framework/ reimbursement structure
                            7.5.1.3. Competitive scenario
                            7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
                        7.5.2. China
                            7.5.2.1. Key country dynamics
                            7.5.2.2. Regulatory framework/ reimbursement structure
                            7.5.2.3. Competitive scenario
                            7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
                        7.5.3. India
                            7.5.3.1. Key country dynamics
                            7.5.3.2. Regulatory framework/ reimbursement structure
                            7.5.3.3. Competitive scenario
                            7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
                        7.5.4. Australia
                            7.5.4.1. Key country dynamics
                            7.5.4.2. Regulatory framework/ reimbursement structure
                            7.5.4.3. Competitive scenario
                            7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
                        7.5.5. South Korea
                            7.5.5.1. Key country dynamics
                            7.5.5.2. Regulatory framework/ reimbursement structure
                            7.5.5.3. Competitive scenario
                            7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
                        7.5.6. Thailand
                            7.5.6.1. Key country dynamics
                            7.5.6.2. Regulatory framework/ reimbursement structure
                            7.5.6.3. Competitive scenario
                            7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
                    7.6. Latin America
                        7.6.1. Brazil
                            7.6.1.1. Key country dynamics
                            7.6.1.2. Regulatory framework/ reimbursement structure
                            7.6.1.3. Competitive scenario
                            7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.2. Argentina
                            7.6.2.1. Key country dynamics
                            7.6.2.2. Regulatory framework/ reimbursement structure
                            7.6.2.3. Competitive scenario
                            7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
                    7.7. MEA
                        7.7.1. South Africa
                            7.7.1.1. Key country dynamics
                            7.7.1.2. Regulatory framework/ reimbursement structure
                            7.7.1.3. Competitive scenario
                            7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
                        7.7.2. Saudi Arabia
                            7.7.2.1. Key country dynamics
                            7.7.2.2. Regulatory framework/ reimbursement structure
                            7.7.2.3. Competitive scenario
                            7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
                        7.7.3. UAE
                            7.7.3.1. Key country dynamics
                            7.7.3.2. Regulatory framework/ reimbursement structure
                            7.7.3.3. Competitive scenario
                            7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
                        7.7.4. Kuwait
                            7.7.4.1. Key country dynamics
                            7.7.4.2. Regulatory framework/ reimbursement structure
                            7.7.4.3. Competitive scenario
                            7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Market Participant Categorization
                    8.2. Recent Developments & Impact Analysis by Key Market Participants
                    8.3. Company Market Share Analysis, 2024
                    8.4. Key Company Profiles
                        8.4.1. Bio-Rad Laboratories, Inc
                            8.4.1.1. Company overview
                            8.4.1.2. Financial performance
                            8.4.1.3. Product benchmarking
                            8.4.1.4. Strategic initiatives
                        8.4.2. Corning Incorporated
                            8.4.2.1. Company overview
                            8.4.2.2. Financial performance
                            8.4.2.3. Product benchmarking
                            8.4.2.4. Strategic initiatives
                        8.4.3. Merck KGaA
                            8.4.3.1. Company overview
                            8.4.3.2. Financial performance
                            8.4.3.3. Product benchmarking
                            8.4.3.4. Strategic initiatives
                        8.4.4. Lonza Group AG
                            8.4.4.1. Company overview
                            8.4.4.2. Financial performance
                            8.4.4.3. Product benchmarking
                            8.4.4.4. Strategic initiatives
                        8.4.5. Charles River Laboratories
                            8.4.5.1. Company overview
                            8.4.5.2. Financial performance
                            8.4.5.3. Product benchmarking
                            8.4.5.4. Strategic initiatives
                        8.4.6. Becton, Dickinson and Company (BD)
                            8.4.6.1. Company overview
                            8.4.6.2. Financial performance
                            8.4.6.3. Product benchmarking
                            8.4.6.4. Strategic initiatives
                        8.4.7. Danaher Corporation
                            8.4.7.1. Company overview
                            8.4.7.2. Financial performance
                            8.4.7.3. Product benchmarking
                            8.4.7.4. Strategic initiatives
                        8.4.8. Promega Corporation
                            8.4.8.1. Company overview
                            8.4.8.2. Financial performance
                            8.4.8.3. Product benchmarking
                            8.4.8.4. Strategic initiatives
                        8.4.9. Thermo Fisher Scientific Inc
                            8.4.9.1. Company overview
                            8.4.9.2. Financial performance
                            8.4.9.3. Product benchmarking
                            8.4.9.4. Strategic initiatives
                        8.4.10. F. Hoffmann-La Roche Ltd.
                            8.4.10.1. Company overview
                            8.4.10.2. Financial performance
                            8.4.10.3. Product benchmarking
                            8.4.10.4. Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 4 Global Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 5 Global Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 6 North America Cell-based Assays market, by region, 2018 - 2030 (USD Million)
Table 7 North America Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 8 North America Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 9 North America Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 10 U.S. Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 11 U.S. Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 12 U.S. Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 13 Mexico Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 14 Mexico Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 15 Mexico Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 16 Canada Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 17 Canada Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 18 Canada Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 19 Europe Cell-based Assays market, by country, 2018 - 2030 (USD Million)
Table 20 Europe Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 21 Europe Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 22 Europe Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 23 UK Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 24 UK Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 25 UK Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 26 Germany Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 27 Germany Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 28 Germany Cell-based Assays market, by End Use 2018 - 2030 (USD Million)
Table 29 France Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 30 France Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 31 France Cell-based Assays market, by End Use 2018 - 2030 (USD Million)
Table 32 Italy Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 33 Italy Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 34 Italy Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 35 Spain Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 36 Spain Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 37 Spain Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 38 Denmark Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 39 Denmark Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 40 Denmark Cell-based Assays market, by End Use 2018 - 2030 (USD Million)
Table 41 Norway Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 42 Norway Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 43 Norway Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 44 Sweden Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 45 Sweden Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 46 Sweden Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Cell-based Assays market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 51 Japan Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 52 Japan Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 53 Japan Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 54 China Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 55 China Cell-based Assays market, by Application 2018 - 2030 (USD Million)
Table 56 China Cell-based Assays market, by End Use 2018 - 2030 (USD Million)
Table 57 India Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 58 India Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 59 India Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 60 Australia Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 61 Australia Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 62 Australia Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 63 South Korea Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 64 South Korea Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 65 South Korea Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 66 Thailand Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 67 Thailand Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 68 Thailand Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 69 Latin America Cell-based Assays market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 71 Latin America Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 72 Latin America Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 73 Brazil Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 74 Brazil Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 75 Brazil Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 76 Argentina Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 77 Argentina Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 78 Argentina Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Cell-based Assays market, by country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 83 South Africa Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 84 South Africa Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 85 South Africa Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 89 UAE Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 90 UAE Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 91 UAE Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)
Table 92 Kuwait Cell-based Assays market, by products & services, 2018 - 2030 (USD Million)
Table 93 Kuwait Cell-based Assays market, by Application, 2018 - 2030 (USD Million)
Table 94 Kuwait Cell-based Assays market, by End Use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Market research approaches
Fig. 4 Value chain-based sizing & forecasting
Fig. 5 Market formulation & validation
Fig. 6 Cell-based Assays market segmentation
Fig. 7 Market driver analysis (current & future impact)
Fig. 8 Market restraint analysis (current & future impact)
Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 10 Porter’s five forces analysis
Fig. 11 Cell-based Assays market, products & services outlook key takeaways (USD Million)
Fig. 12 Cell-based Assays market: products & services movement analysis (USD Million), 2023 & 2030
Fig. 13 Cell-based Assays market: application movement analysis (USD Million), 2023 & 2030
Fig. 14 Cell-based Assays market: end use movement analysis (USD Million), 2023 & 2030
Fig. 15 Reagents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 Assay Kits market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Cell Growth Assays market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Reporter Gene Assays market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Cell Death Assays market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Second Messenger Assays market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Microplates market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Probes & Labels market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Instruments & Software market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Cell Lines market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Primary Cell Lines market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Stem Cell Lines market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Immortalized Cell Lines market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Basic Research market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Drug Discovery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Other Applications market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Pharmaceutical & Biotechnology Companies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Academic & Research Institutes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Contract Research Organizations market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 North America Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 U.S. Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Canada Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Mexico Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Europe Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 UK Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Germany Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 France Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Spain Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Italy Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Norway Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Denmark Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Sweden Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Asia Pacific Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 China Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Japan Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 India Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 South Korea Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Australia Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Thailand Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Latin America Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Brazil Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Argentina Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Middle East and Africa Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 South Africa Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Saudi Arabia Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 UAE Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Kuwait Cell-based Assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 List of key emerging company’s/Allergen disruptors/innovators